The COVID-19 pandemic has created significant challenges for people living with diabetes. Some patients have thrived with the increased emphasis of self-management, where other vulnerable populations have struggled with a decrease in support in maintaining glycaemic control and optimising management.
This patient case will review the clinical considerations of a vulnerable older adults with type 2 diabetes who is currently using insulin.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.